Brazil is a strategic market for many local and foreign pharmaceutical companies due to its protective legislation with regard to access to healthcare. However, its pharma ecosystem is complex and requires a comprehensive understanding of the legal framework that governs IP protection.
IAM talked with Petro Terblanche, CEO of Afrigen Biologics, about the WHO vaccine hub and its IP strategy
Disappointment with last year’s WTO agreement on suspending patent rights to secure covid-19 vaccine supplies has led campaigners to intensify calls for a new agreement that would include know-how
Consumers have grown accustomed to purchasing goods and services through various online channels, and these new e-commerce models have made IP rights infringement even more widespread. This is presenting fresh challenges in brand protection, evidence collection, enforcement models and legal applications.
27 September 2023
Although application numbers are on the rise, the cost, length and venue of litigation are just some of the deterrents preventing rights holders from filing litigation in the Philippines. It is imperative to meet these challenges in order to incentivise enforcement and encourage innovation.
25 August 2023
The legal industry has been left permanently altered from the pandemic. Five thought leaders provide their exclusive take into what these changes look like from the inside
25 November 2022
While WTO member states have expressed general sympathy for the goal to provide broad access to vaccine technology during the pandemic, Germany continues to favour patent protection over compulsory licensing.
16 November 2022
Turkey’s recent compulsory licence decision shines a light on the questionable use of compulsory licence provisions around the world in relation to the pandemic. The creation of the covid vaccine has sparked discussions on IP rights and where the real regulatory focus should be.
28 September 2022
Dr Michael A Sartori and Sarah Hassan of Baker Botts explore the impact that covid-19 has had on new application filings and application abandonments, revealing some interesting contrasts with previous financial disruptions
13 September 2022
Dolby Laboratories’ director of IP strategy and operations provides best practices for building valuable patent and trademark portfolios against a backdrop of global crises
08 September 2022
Companies seek non-infringement and invalidity judgment against CureVac, which launched a suit against them in Germany in July
06 September 2022
Disputes increased the most in technology centres covering computers, semiconductors and networking while patent owners won favourable determinations in many cases
22 August 2022
Unlock unlimited access to all IAM content
